// App-Quantinova.ai

2354 : Cancer vaccine development for hepatocellular carcinoma - HEPAVAC

Researchers

Presenter

  • Sarah Kutscher

Principal Investigators

  • Roberto Accolla

  • Yuk T. Ma

  • Regina Heidenreich

  • Francesco Izzo

  • Alfred Koenigsrainer

  • Markus Loeffler

  • Phillip Mueller

  • Andrea Mayer

  • Hans-Georg Rammensee

  • Bruno Sangro

  • Sven Francque

  • Danila Valmori

  • Toni Weinschenk

  • Harpreet Singh-Jasuja

  • Luigi Buonaguro

Medical Centers

  • Immatics Biotechnologies GmbH, Tubingen, Germany

  • University of Insubria, VARESE, Italy

  • University of Birmingham, Birmingham, United Kingdom

  • Curevac GMBH, Tuebingen, Germany

  • National Cancer Institute, Aviano, Italy

  • University of Tubingen, Tubingen, Germany

  • University of Navarra, PAMPLONA, Spain

  • University of Antwerp, ANTWERP, Belgium

  • INSERM, NANTES, France.

Locations

  • Italy

  • Germany

  • Spain

  • United Kingdom

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • CVac

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved